The Study / Glow Skin

Rejuran vs Re2O: How to Choose

August 23, 2026·4 min read·By the DayBeau Gangnam Medical Team

Rejuran delivers salmon-derived polynucleotides, while Re2O places extracellular matrix from donated human dermal tissue with cells removed into the dermis.

Rejuran and Re2O both work in the dermis, but they approach it from opposite directions. Rejuran delivers polynucleotides (PN) derived from salmon, and is approved in Korea to temporarily improve facial wrinkles. Re2O places extracellular matrix (ECM) — taken from donated human dermal tissue with the cells removed — directly into the dermis. One uses polynucleotides, the other donor-derived matrix: that difference is the heart of the decision.

Rejuran Healer and Elravie Re2O packages placed side by side on Korean hanji paper

Why these two are always mentioned together

In consultation, Rejuran and Re2O come up in the same breath almost every time. Both are injected across the face in small amounts, both are described as improving skin texture, and both take a similar amount of time with a similar recovery.

So the question arrives: which one is better? But what separates them isn't performance. It's where the material comes from.

What the skin loses is not only collagen

Something needs establishing first. What thins with age is not collagen alone.

The dermis is a mesh — collagen, elastin, hyaluronic acid and other components woven into a single structure. That whole structure is called the extracellular matrix, or ECM. Collagen is one thread in it.

Aging is less a matter of collagen running low and more a matter of the whole mesh growing loose. Holding that picture in mind is what makes the difference between these two treatments legible.

Rejuran: a polynucleotide booster

Rejuran Healer delivers polynucleotides extracted from salmon into the dermis. PN is not a material that fills the mesh on the skin's behalf. How it acts varies by person, and your doctor explains what to expect.

Change, if any, may take time to appear. When it does, it is the kind read through texture and resilience, through fingertips and expression rather than a mirror alone.

It comes up when the concern is texture and sensitivity: texture that has roughened, a sense of thinness, skin that reacts more easily than it used to. PN boosters have been used in Korea for some time and are among the best-known booster categories here.

Re2O: laying down a mesh already woven

Re2O reverses the approach. Rather than asking the skin to weave, it brings a mesh that is already woven.

That mesh comes from donated human skin tissue. Once cells and the elements capable of provoking an immune response are removed, what remains is the ECM structure — a material called hADM, human acellular dermal matrix. Refined into fine particles, it is placed into the dermis. According to the manufacturer, collagen makes up most of it, alongside elastin and other structural components.

Timing varies by person. This is a different kind of change from the dewy, light-catching finish of hydration-led treatments. What shifts is not the surface but the density underneath it.

It comes up when the density of the dermis is what catches your eye first: skin that has thinned, that reads as loose or sparse, pores and fine lines that have become more visible.

On the fact that it comes from human tissue

There is one point we always explain when discussing Re2O: the material originates from donated human tissue.

In Korea, acellular dermal matrix has long been used in reconstructive care for burn patients, and your consultant will explain how the material is documented. According to the manufacturer, the processing removes cells, genetic material and immune antigens, leaving only the structural components.

And this is precisely what gives the category its character. Re2O places donor-derived matrix rather than a material meant to provoke a response from the body. Because what is placed is the same kind of material the skin is already made of, the body is not being asked to recognize anything foreign. Reactions are still possible, and your doctor reviews your history first.

Even so, we think it is better that you know this beforehand. A treatment should be chosen after the principle is understood, not before. Ask us anything about it in consultation.

Side by side

Rejuran HealerRe2O
MaterialPolynucleotides from salmonECM from donated human tissue (hADM)
ApproachPolynucleotide boosterPlaces donor-derived matrix
When change registersVaries by personVaries by person
Mainly addressesTexture, sensitivityDermal density, substance
The body's responseIndividual reactions varyIndividual reactions vary; your doctor reviews your history
CategoryPN boosterECM booster

Neither column sits above the other. A newer category is not therefore better, and an established one is not therefore behind. The question worth asking is: does my skin need a polynucleotide booster, or donor-derived material?

If, in the mirror, your skin looks reactive and tired, the issue is more likely one of texture and sensitivity. If it looks thin and sparse, the issue is more likely one of density. That distinction is where most consultations begin.

When both are used together

Skin rarely presents one problem at a time. Thinning alongside increased sensitivity is the most common picture of all.

The two treatments differ in material and in mechanism, so they are often planned together. A common design uses each at a different point in the plan. Using them together isn't an unusual combination — it's an ordinary one.

Re2O belongs to a wider category that is newer in Korea. We look at it in more detail in our piece on ECM boosters.

What the consultation actually decides

A doctor looks at the thickness and condition of your skin, the direction it has changed in recently, and what treatments you have had before. Skin that turned sensitive over a few months and skin that has been thinning for years are not approached the same way.

At DayBeau Gangnam, we settle on the treatment and its structure after that assessment. Because responses and duration differ from person to person, the decision follows the diagnosis rather than preceding it.

These two treatments are not competing. One is a polynucleotide booster; the other places donor-derived matrix. Which one you need right now is the answer.

Written by the DayBeau Gangnam Medical Team · Medically reviewed by the DayBeau Gangnam Medical Team

A signal, or material?

The answer starts with what your skin is missing right now.

Book a consultation→
WhatsApp · LINE · WeChat · KakaoTalk
Book a Consultation
Chat on WhatsApp
Chat on LINE
@daybeauglobal